Header Ads

Developing antibody standards for Covid

Coronavirus Daily
Bloomberg

Here's the latest news from the global pandemic.

Developing Antibody Standards for Covid

Siemens Healthineers has joined U.S. and European health officials to create an international standard for coronavirus antibody tests, a key step toward knowing who needs a future vaccine or booster shot.

The effort aims to establish a unit of measurement for the level of protection someone has built up against the deadly virus. The project from Healthineers, the U.S. Centers for Disease Control and Prevention and the European Commission's Joint Research Centre will probably take a matter of "weeks, not months," Deepak Nath, president of laboratory diagnostics at Healthineers, said in an interview.

As Healthineers and other companies bring more sophisticated tests to market that can gauge the amount of antibodies in someone's blood—rather than ones that simply say whether they're present—it's important to have an agreed-upon yardstick for those concentration levels. Healthineers is at the forefront of creating that standard because it is the first company to win clearance from the U.S. Food and Drug Administration for a test that quantifies antibody levels.

An employee checks the temperature of a visitor at the entrance of a Siemens Healthineers factory in Shanghai earlier this year.

Photographer: Qilai Shen/Bloomberg

"This work has to be done and it makes sense for us to do it," Nath said. "We're trying to make sure that as vaccines hit the market, the right diagnostic tools are available to complement what the vaccine companies are doing."

Without a standard of measurement, results can't easily be compared with those from other companies' tests. Swiss giant Roche Holding has said it plans to bring its own quantitative antibody test to market in coming months.

Researchers will also be able to use the standard to determine a level of antibodies that appears to confer immunity against infection. Health officials can then determine whether someone who previously fought off the virus needs a vaccine, once shots are available—or whether someone who's already been inoculated needs a booster shot.

It could also be useful for monitoring vaccines' performance once they are approved, to see how long shots provide protection.

Antibodies are highly specific proteins raised by the immune system to disable viral invaders. They're also markers of infection that help health officials know how far the virus has spread.—Tim Loh

Latest podcast

The Slim Chance of a Cure

Prevention with vaccines has been far more successful than treatment with drugs. In fact, modern medicine has come up with a true cure for only one viral infection. Michelle Fay Cortez reports, and get the episode here

 

What you should read

Covid May Sub Some Human Jobs With Machines
To avoid virus spread, automation has increased—potentially permanently. 
Where's the Cure? The Body Still Best Virus-Killer
In virus struggles, prevention with vaccines more successful than drugs.
Holiday Spending Seen Rising Despite Covid-19
Retailers try to recover from dramatic pullback in discretionary purchases.
Lagarde Uses Virus for Greener Monetary Policy
Lagarde hasn't allowed the virus recession to bump climate off her agenda.
The Cruise Ship That Spread Covid to the World
Hundreds infected Ruby Princess passengers were allowed to disembark.

Know someone else who would like this newsletter?  Have them sign up here.

Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story.

Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close.

No comments